Kestra Advisory Services’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$592K Sell
17,089
-4,615
-21% -$124K ﹤0.01% 2223
2026
Q1
$451K Sell
21,704
-7,776
-26% -$184K ﹤0.01% 2301
2025
Q4
$957K Sell
29,480
-20,047
-40% -$859K ﹤0.01% 1684
2025
Q3
$2.81M Buy
49,527
+15,855
+47% +$812K 0.01% 970
2025
Q2
$1.68M Buy
33,672
+19,995
+146% +$904K 0.01% 1174
2025
Q1
$404K Sell
13,677
-970
-7% -$36K ﹤0.01% 1966
2024
Q4
$354K Buy
+14,647
New +$363K ﹤0.01% 2116

Other funds holding HIMS

Kestra Advisory Services's HIMS Position: Q2 2026 in Review

Kestra Advisory Services reduced its Hims & Hers Health (HIMS) stake by 21% in Q2 2026, selling an estimated $124K and leaving 17,089 shares worth $592K. The position accounts for ﹤0.01% of the portfolio, ranked #2223.

Kestra Advisory Services first reported a position in HIMS in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.81M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Kestra Advisory Services held 17,089 shares of Hims & Hers Health worth $592K as of Q2 2026.
  • Kestra Advisory Services sold 4,615 Hims & Hers Health shares in Q2 2026, an estimated $124K.
  • Hims & Hers Health made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #2223 holding.
  • Kestra Advisory Services first reported a position in Hims & Hers Health in Q4 2024 and has held it in 7 quarters since.
  • Kestra Advisory Services's Hims & Hers Health position peaked at $2.81M in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.